Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant human coagulation factor viii-fc fusion protein
- Development stage
- Phase 3
- Lead developer
- Zhengzhou Gensciences
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Administration
- Injection
01
Overview
Recombinant human coagulation factor VIII-Fc fusion protein is a pharmaceutical drug developed by Zhengzhou Gensciences Inc. for the treatment of hemophilia A. This fusion protein is designed to replace the deficient coagulation factor VIII in patients with hemophilia A, thereby restoring proper blood clotting function. It is administered via injection.
- Brand names
- EloctateElocta
- Other names
- recombinant human coagulation factor VIII-Fc fusion protein for injection
02
Targets
FCGR3A (Low affinity immunoglobulin gamma Fc region receptor III-A)FCGRT (Neonatal crystallizable fragment receptor)F10 (Factor Xa)Coagulation Factor IXaLRP1 (Prolow-density lipoprotein receptor-related protein 1)
Beyond the preview
Go deeper on recombinant human coagulation factor viii-fc fusion protein.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant human coagulation factor viii-fc fusion protein.